Showing results (1251-1260 of 3,896) with videos related to

Sort By:
Pageof 390
Disease Markers|October 1, 1994
Effect of interferon-gamma and TNF-alpha on MUC1 mucin expression in ovarian carcinoma cell linesS Clark, M A McGuckin, T Hurst, et al.
Disease Markers|October 20, 2022
Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder CancerShuo Wu, Shipei Qiu, Wei Chen, et al.
Disease Markers|October 21, 2022
Low Prognostic Nutritional Index Contributes to High Adverse Events in PreeclampsiaSongquan Wei, Liyou Lian, Guimin Li, et al.
Disease Markers|October 21, 2022
Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-AnalysisShirin Sarejloo, Matin Moallem Shahri, Pouria Azami, et al.
Disease Markers|September 6, 2022
Oral Health Self-Management Ability and Its Influencing Factors among Adolescents with Fixed Orthodontics in China: A Mixed Methods StudyYan Li, Jian Liu, Yingxin Xu, et al.
Disease Markers|February 10, 2021
VDR Gene Polymorphisms in Healthy Individuals with Family History of Premature Coronary Artery DiseaseMartyna Fronczek, Joanna Katarzyna Strzelczyk, Tadeusz Osadnik, et al.
Disease Markers|February 25, 2021
Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7Toshiya Miyauchi, Masahiro Takahashi, Koji Mitsuzuka, et al.
Disease Markers|February 22, 2021
Assessment and Management of Cardiotoxicity in Hematologic MalignanciesAnca Bojan, Tunde Torok-Vistai, Andrada Parvu
Disease Markers|February 12, 2021
Increased Expression of DNA2 Was Linked to Poor Prognosis in Breast CancerYingyan Han, Zeyu Zhang, Zhi Wang, et al.
Disease Markers|February 12, 2021
Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-AnalysisGuangying Guo, Aoran Huang, Xin Huang, et al.
Pageof 390